Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-20 Sale | 2024-08-22 4:14 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 22,458 | $24.49 | $549,928 | 327,029 (Indirect Direct) | View |
| 2024-08-13 Sale | 2024-08-15 4:09 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,337 | $22.89 | $53,494 | 349,487 (Indirect Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:14 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,189 | $17.46 | $73,130 | 351,824 (Indirect Direct) | View |
| 2024-01-10 Sale | 2024-01-12 8:18 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,668 | $19.02 | $88,785 | 356,013 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-09 7:35 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 9,972 | $19.43 | $193,756 | 360,681 (Indirect Direct) | View |
| 2023-08-23 Sale | 2023-08-25 5:30 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,522 | $23.22 | $58,561 | 316,933 (Indirect Direct) | View |
| 2023-08-21 Sale | 2023-08-23 4:34 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,478 | $22.6 | $56,003 | 319,455 (Indirect Direct) | View |
| 2023-08-14 Sale | 2023-08-16 6:20 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,768 | $23.79 | $65,851 | 321,933 (Indirect Direct) | View |
| 2023-08-10 Sale | 2023-08-14 5:12 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,857 | $24.15 | $68,997 | 324,701 (Indirect Direct) | View |
| 2023-02-15 Sale | 2023-02-17 4:20 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 1,476 | $29.4 | $43,394 | 327,558 (Indirect Direct) | View |
| 2023-02-10 Sale | 2023-02-14 7:06 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 3,366 | $30.03 | $101,071 | 329,034 (Indirect Direct) | View |
| 2023-02-08 Sale | 2023-02-10 6:12 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 1,521 | $30.88 | $46,968 | 332,400 (Indirect Direct) | View |
| 2023-01-09 Sale | 2023-01-10 4:51 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 1,459 | $28.48 | $41,552 | 333,921 (Indirect Direct) | View |
| 2023-01-05 Sale | 2023-01-09 9:43 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,087 | $28.52 | $116,568 | 335,380 (Indirect Direct) | View |
| 2023-01-04 Sale | 2023-01-05 9:08 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,913 | $28.69 | $83,574 | 462,827 (Indirect Direct) | View |
| 2022-08-23 Sale | 2022-08-25 6:10 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,424 | $31.98 | $77,520 | 301,260 (Indirect Direct) | View |
| 2022-08-19 Sale | 2022-08-23 4:45 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,576 | $33.22 | $85,575 | 303,684 (Indirect Direct) | View |
| 2022-02-11 Sale | 2022-02-15 6:53 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,918 | $34.71 | $101,284 | 283,760 (Indirect Direct) | View |
| 2022-02-09 Sale | 2022-02-11 5:16 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 1,423 | $37.1 | $52,791 | 286,678 (Indirect Direct) | View |
| 2022-01-05 Sale | 2022-01-07 6:05 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,845 | $44.78 | $127,399 | 288,101 (Indirect Direct) | View |
| 2021-12-06 Sale | 2021-12-08 5:35 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 1,476 | $42.52 | $62,760 | 259,946 (Indirect Direct) | View |
| 2021-08-23 Sale | 2021-08-25 6:26 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 6,143 | $48.91 | $300,454 | 261,422 (Indirect Direct) | View |
| 2021-08-19 Sale | 2021-08-23 8:25 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,546 | $49.58 | $126,230 | 267,565 (Indirect Direct) | View |
| 2021-03-29 Sale | 2021-03-31 6:30 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,822 | $54.62 | $154,126 | 269,701 (Indirect Direct) | View |
| 2021-03-01 Sale | 2021-03-03 4:21 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 7,092 | $66.38 | $470,741 | 272,523 (Indirect Direct) | View |
| 2021-02-11 Sale | 2021-02-16 7:43 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 3,156 | $70.33 | $221,972 | 279,615 (Indirect Direct) | View |
| 2021-02-09 Sale | 2021-02-11 7:10 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 1,470 | $74.68 | $109,785 | 202,897 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-25 Exercise | 2024-11-27 4:44 pm | N/A 2025-08-20 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 17,845 | $0 | 452,029 (Direct) | View |
| 2024-11-25 Exercise | 2024-11-27 4:44 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 17,845 | $0.68 | 452,029 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:47 pm | N/A 2034-06-05 | Beam Therapeutics Inc. | BEAM | Ho Carole Director | 23,114 | $0 | 23,114 (Direct) | View |
| 2024-04-05 Disposition | 2024-04-08 4:14 pm | N/A 2033-05-09 | NGM BIOPHARMACEUTICALS INC | NGM | Ho Carole Director | 161,763 | $0 | 0 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 5:57 pm | N/A 2034-01-02 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 214,880 | $0 | 531,813 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:49 pm | N/A 2033-06-06 | Beam Therapeutics Inc. | BEAM | Ho Carole Director | 16,532 | $0 | 16,532 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 5:48 pm | N/A 2033-05-09 | NGM BIOPHARMACEUTICALS INC | NGM | Ho Carole Director | 78,407 | $0 | 78,407 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 9:08 pm | N/A 2033-01-02 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 164,480 | $0 | 462,827 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-02 4:05 pm | N/A 2032-09-01 | Beam Therapeutics Inc. | BEAM | Ho Carole Director | 10,391 | $0 | 10,391 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-11 7:22 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 22,500 | $0 | 306,260 (Direct) | View |
| 2022-05-18 Option Award | 2022-05-20 6:22 pm | N/A 2032-05-17 | NGM BIOPHARMACEUTICALS INC | NGM | Ho Carole Director | 24,222 | $0 | 24,222 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:03 pm | N/A 2032-01-02 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 124,000 | $0 | 383,946 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 07:57 am | N/A 2031-06-10 | Beam Therapeutics Inc. | BEAM | Ho Carole Director | 6,877 | $0 | 6,877 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 5:39 pm | N/A 2031-06-07 | NGM BIOPHARMACEUTICALS INC | NGM | Ho Carole Director | 19,619 | $0 | 19,619 (Direct) | View |
| 2021-02-07 Exercise | 2021-02-11 7:10 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,250 | $0 | 202,897 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 6:54 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 120,000 | $0 | 120,000 (Direct) | View |